Tumor stroma-derived LCN2, particularly that secreted by M2 macrophages via STAT3 and C/EBPβ signaling pathways, induces EMT in MCF-7 breast cancer cells, thereby enhancing their migration and invasion capabilities in both in vitro and in vivo models (55). This evidence concerns the gene LCN2 and breast cancer.